Genome Research
Washington Post | Steno ‘Superbug’ Genome Shows Extreme Drug Resistance
FRIDAY, May 9 (HealthDay News) British research into Steno, one the most recent “superbugs” to claim lives, reveals that the bacterium has an incredible ability to resist antibiotics and other drugs, according to soon-to-be-published findings.
Steno, short forStenotrophomonas maltophilia, thrives in moist environments, such as around taps and shower heads, and can be transmitted to people. It is responsible for roughly 1,000 cases of Steno blood poisoning in the U.K. annually. About 30 percent of these infections prove fatal.
ABC | Platypus genome explored in nature journal
But its unique characteristics of the platypus have fascinated scientists since it was discovered and today the monotreme’s genome will be published for the first time in the journal Nature.
Chron.com | Human Genome Sciences shares fall as 1Q results disappoint
NEW YORK — Shares of biotechnology company Human Genome Sciences Inc. fell Tuesday after the company’s first-quarter results disappointed investors.
Shares fell 50 cents, or 7.5 percent, to $6.13. The stock has traded between $4.74 and $11.95 over the last 52 weeks.